Inception Return
(10/28/1996)
|
10.09 %
|
|
YTD Return
|
13.45 %
|
|
NAVPS
(11/10/2026)
|
$268.95
|
|
Change
|
($0.53) / -0.20 %
|
|
|
Growth of $10,000
(As of October 31, 2026)
|
|
MER
|
2.23 %
|
|
Assets ($mil)
|
$635.67
|
|
Rank (1Yr)
|
498/2098
|
|
Std Dev (3Yr)
|
15.38 %
|
|
Volatility Ranking (3Yr)
|
9/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or No Load
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
5.50 %
|
|
Sales Status
|
Open
|
|
|
Objective
To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. We will not change the Fund’s fundamental investment objectives without the consent of unitholders by a majority of votes cast at a meeting of unitholders.
|
Fund Manager
CIBC Asset Management Inc.
Portfolio Manager
Craig Jerusalim, CIBC Asset Management Inc.
Michal Marszal, CIBC Asset Management Inc.
Mickey Ganguly, CIBC Asset Management Inc.
Sub-Advisor
-
|
|
Asset Allocation
(As of October 31, 2026)
|
Sector Allocation
(As of October 31, 2026)
|
Geographic Allocation
(As of October 31, 2026)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| NVIDIA Corp | US Equity | Technology | United States | 7.88% |
| Alphabet Inc Cl A | US Equity | Technology | United States | 7.57% |
| Apple Inc | US Equity | Technology | United States | 7.13% |
| Roche Holding AG | International Equity | Healthcare | Other European | 6.52% |
| Microsoft Corp | US Equity | Technology | United States | 5.65% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 5.30% |
| Medtronic PLC | International Equity | Healthcare | European Union | 4.88% |
| Novartis AG Cl N | International Equity | Healthcare | Other European | 4.30% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 4.23% |
| Meta Platforms Inc Cl A | US Equity | Technology | United States | 4.13% |
Performance Data
(As of October 31, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-5.93
|
1.04
|
9.64
|
13.45
|
12.99
|
23.78
|
11.00
|
17.65
|
|
Benchmark
|
-3.32
|
-0.77
|
6.41
|
13.11
|
11.85
|
22.41
|
12.56
|
12.76
|
|
Quartile Ranking
|
4
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
16.48
|
30.67
|
30.23
|
-20.88
|
3.16
|
47.03
|
34.81
|
7.27
|
31.06
|
-3.31
|
|
Benchmark
|
16.60
|
26.84
|
19.37
|
-12.64
|
17.62
|
13.15
|
21.41
|
-1.79
|
16.29
|
5.18
|
|
Quartile Ranking
|
2
|
1
|
1
|
4
|
4
|
1
|
1
|
1
|
1
|
4
|